Skip to main content

HPA Global

JD Health Signs Agreements With More Than 20 Global Healthcare Brands at China International Import Expo, Including HPA-Global Member Jamieson

November 6, 2026

China’s leading online healthcare platform, JD Health, announced new cooperation agreements with more than 20 international pharmaceutical, nutritional supplement, and medical device companies during the ninth China International Import Expo (CIIE), held November 5–10 in Shanghai.

The agreements involve major international companies, including Pfizer, Merck, Novo Nordisk, Centrum, Caltrate, HPA-Global member Jamieson Wellness, Omron, and Siemens.

The partnerships reflect JD Health’s continued expansion as a major distribution and healthcare services platform, connecting international brands with Chinese consumers through e-commerce, online medical consultations, and integrated healthcare services.

According to JD Health CEO Cao Dong, the company has established extensive partnerships with 50 of the world’s leading multinational pharmaceutical manufacturers. JD Health also reports that it has maintained its position as China’s largest pharmaceutical retail platform by revenue for several consecutive years.

During the first nine months of 2026, more than 100 new pharmaceutical products made their online debuts through JD Health, exceeding the total number introduced during all of 2025.

Several international healthcare companies reported strong sales growth through JD Health’s platform. AstraZeneca recorded a 51.1% year-over-year increase in sales through JD Health’s self-operated channel during the first nine months of 2026, while Organon reported 42% growth in transaction value.

Haleon, which marked ten years of cooperation with JD Health, reported that transaction value for its products on the platform increased more than 50% in 2025.

In addition to expanding international brand partnerships, JD Health announced the introduction of a new medical-tourism service designed to help overseas patients access healthcare services in China.

The initiative will initially focus on patients from Qatar, the United Arab Emirates, Kazakhstan, and Indonesia, providing assistance with hospital appointments, travel arrangements, interpretation, and follow-up care.

What this means for the industry

JD Health’s latest agreements highlight the growing importance of China’s integrated healthcare and e-commerce platforms for international dietary supplement, functional food, and consumer health brands.

The inclusion of established nutritional supplement companies such as Jamieson, Centrum, and Caltrate demonstrates that JD Health’s international partnerships extend beyond prescription pharmaceuticals into nutritional products and preventive health.

For international supplement companies, platforms such as JD Health offer opportunities to reach Chinese consumers through established distribution networks, digital marketing, and healthcare-oriented retail channels.

However, entering these channels requires careful attention to China’s regulatory requirements, including product classification, registration or filing obligations where applicable, labeling, advertising claims, and differences between domestic distribution and cross-border e-commerce.

For HPA-Global member Jamieson Wellness, participation in JD Health’s expanded international partnership network represents a noteworthy development in the company’s engagement with China’s consumer health market. The announcement does not specify the commercial terms or individual product commitments associated with Jamieson’s agreement.

The development also illustrates the increasing convergence of nutritional supplements, digital healthcare, and online retail in China, creating opportunities for international companies seeking to expand their presence in one of the world’s largest consumer health markets.

Source: BigGo Finance, reporting on JD Health’s announcements at the ninth China International Import Expo, November 2026.

Original source: JD Health Signs Deals With 20+ Global Drugmakers at China International Import Expo


About HPA-Global

HPA-Global supports dietary supplement, functional food, ingredient, and consumer health companies through international market intelligence, regulatory guidance, industry visibility, and business connections across China, Greater Asia, and other major global markets.

If your company is looking to expand internationally, understand evolving regulations, or increase its visibility within the global nutrition and health products industry, we invite you to explore the benefits of HPA-Global membership.

For more industry news, visit: www.hpaglobal.org/news

For more information about HPA-Global membership and services, visit: www.hpaglobal.org/connect